论文部分内容阅读
目的探讨新生儿缺血缺氧性脑病(HIE)合并蛛网膜下腔出血(SAH)患儿的临床治疗方法。方法选取医院2012年12月-2013年12月新生儿HIE合并SAH患儿8例,设为A1组(观察组);同期选择新生儿患儿8例,设为A2组(对照组)。A2组:采用常规西药完成治疗;A1组:采用常规西药+高压氧完成治疗。对比A1组与A2组HIE合并SAH患儿完成治疗后的临床效果。结果 A1组与A2组患儿完成治疗后,在治疗的总有效率方面,A1组高于A2组患儿,差异有统计学意义(P<0.05)。结论针对新生儿HIE合并SAH患儿,采用常规西药+高压氧的方法进行治疗,临床获得的疗效显著,凸显联合用药治疗的应用价值。
Objective To investigate the clinical treatment of neonates with hypoxic-ischemic encephalopathy (HIE) complicated with subarachnoid hemorrhage (SAH). Methods Eight children with neonatal HIE complicated with SAH from December 2012 to December 2013 were selected as group A1 (observation group). Eight neonates were selected during the same period as A2 group (control group). Group A2: Western medicine was used to complete the treatment; Group A1: Western medicine and hyperbaric oxygen were used to complete the treatment. To compare the clinical effect of A1 group and A2 group with HIE complicated with SAH in children. Results After the treatment of children in group A1 and group A2, the total effective rate in group A1 was higher than that in group A2, the difference was statistically significant (P <0.05). Conclusion In neonates with HIE complicated with SAH, the treatment with conventional Western medicine and hyperbaric oxygen therapy is clinically significant, which highlights the clinical value of combination therapy.